Study S002802

A Study to Evaluate the Effect of GZR18 Injection on Gastric Emptying and Its Drug-Drug Interactions With Digoxin, Rosuvastatin Calcium and Warfarin Sodium in Obese or Overweight Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07128888
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 60
Start: 2025-11-17
Primary completion: 2026-07-05
Lead sponsor: Gan & Lee Pharmaceuticals.
Conditions: Obesity or Overweight
Interventions: DRUG:GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets
Results posted: FALSE

Registered primary outcomes

Cmax:Maximum plasma concentration [through study completion,up to 16 weeks]
AUC0-last:Area under the plasma concentration-time curve at 0 h to last observation time-point after a single dose. [through study completion,up to 16 weeks]
AUC0-inf:Area under the plasma concentration-time curve at 0 h to infinity after a single dose. [through study completion,up to 16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.